Hookipa Pharma Inc

$7.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.28 (3.69%) As of 10:20 AM EDT today
+$0.28 (3.69%) Today

Why Robinhood?

You can buy or sell HOOK and other stocks, options, ETFs, and crypto commission-free!

About HOOK

HOOKIPA Pharma, Inc. engages in the development of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary its arenavirus platform that is designed to reprogram the body's immune system. Its product include VaxWace, a replication-deficient viral vector; and TheraT, a replication-attenuated viral vector, are designed to induce robust antigen specific CD8+ T cells and pathogen-neutralizing antibodies. Read More The company was founded by Rolf Zinkernagel, Andreas Bergthaler, Lukas Flatz, and Daniel Pinschewer in 2011 and is headquartered in New York, NY.

Employees
56
Headquarters
New York, New York
Founded
2011
Market Cap
192.60M
Price-Earnings Ratio
Dividend Yield
Average Volume
20.71K
High Today
$7.86
Low Today
$7.52
Open Price
$7.52
Volume
609.00
52 Week High
$14.76
52 Week Low
$6.06

Collections

HOOK Earnings

-$0.63
-$0.59
-$0.55
-$0.51
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 7, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.